Lenz Therapeutics Inc (LENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 58,610 | 72,429 | 105,639 | 60,443 | 13,500 |
| Operating Income | -58,610 | -72,429 | -105,639 | -60,443 | -13,500 |
| Other Income | 8,842 | 2,282 | 4,587 | -10,317 | -54,873 |
| Pre-tax Income | -49,768 | -70,147 | -101,052 | -70,760 | -68,373 |
| Income Tax | 1 | -179 | N/A | N/A | N/A |
| Net Income Continuous | -49,769 | -69,968 | -101,052 | -70,760 | -68,373 |
| Net Income | $-49,769 | $-69,968 | $-101,052 | $-70,760 | $-68,373 |
| EPS Basic Total Ops | -2.34 | -35.71 | -12.88 | -17.14 | -209.45 |
| EPS Basic Continuous Ops | -2.34 | -35.72 | -12.89 | -17.12 | -209.49 |
| EPS Diluted Total Ops | -2.34 | -35.71 | -12.88 | -17.14 | -209.45 |
| EPS Diluted Continuous Ops | -2.34 | -35.72 | -12.89 | -17.12 | -209.49 |
| EPS Diluted Before Non-Recurring Items | -2.34 | N/A | -12.88 | -17.15 | N/A |
| EBITDA(a) | $-62,569 | $-73,471 | $-104,887 | $-59,709 | $-13,379 |